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Postparatbyroidectomy behavior of calcium metabolism in renal stone
former patients with primary hyperparathyroidism. A. Aroldi, G. Gra-
ziani, G. Colussi, M. Surian, D. Rurale, E. Lorenzano, C. Tommasini
Degna, and C. Ponticelli. Divisioni di Nefrologia e Dialisi, Ospedali
Pa/ic/mica e Niguarda Ca' Granda, Milano, Italy. Calcium metabolism
before and after I to 9 years after parathyroidectomy (PTX) was
evaluated in 24 renal stone former patients with primary hyperparathy-
roidism. All patients had a single enlarged parathyroid gland surgically
removed, while the other glands, carefully searched for, were of normal
macroscopic size. During the follow-up in 17 patients total (pCa) and
ionized (pCa) plasma calcium, immunoreactive parathyroid hormone
(iPTH), urinary calcium excretion and cAMPE remained in the normal
range. In five patients "absorptive" hypercalciuria was observed 6, 8,
12, 26 and 63 months after PTX; daily urinary calcium excretion (UcV
386 92; n.y. 300 mg/24 hr) was elevated, while fasting calcium
excretion (CaE: 0.05 0.02; n.v.0.l2 mg/dl GFR), pCa and iPTH
were normal as was plasma 1.25 (OH)2D3 (29.8 5.4; n.y. 33 15 pg/
ml). In two patients hyperparathyroidism recurred 0.5 to 6 years after
PTX, as suggested by high pCa (5.32, 5.30; nv, 5.l mg/dl), iPTH
(2.6, 3.0; nv. l.4 ng/ml), daily urinary calcium excretion (UcV: 429,
385 mg/24 hr) and fasting Ca (0.13, 0.24 mg/dl GFR), whereas pCa
(10.2, 10.3; nv. 10.5 mg/dl) was below 2 so of the normal range. Thus,
although most patients (71%) maintain normalization of calcium nietab-
olism after PTX, in a non-negligible percentage (21% in this study) of
patients "de novo," "absorptive" hypercalciuria develops. These data
suggest that careful metabolic assessment still must be evaluated
periodically.
The role played by acid mucopolysaccharides in calcium oxalate
nephrolithiasis. B. Baggia, G. Gambaro, L. Dc Nardo, and A. Borsatti.
Clinica Medica I de/l'finiversitd, Padava, Italy. Urinary acid muco-
polysaccharides (AMPs) have been considered as the most potent
inhibitors of calcium-oxalate crystal growth and aggregation. However.
the mechanism by which this inhibitory activity takes place is unclear.
It is possible that AMPs bind calcium making up weak complexes. On
the other hand, uric acid also seems to be capable to bind to AMPs
removing them from the solution such favoring the precipitation of
calcium salts. Following this hypothesis, the binding affinity was
checked with calcium and uric acid of two AMPs, chondroitin (CS) and
heparan sulfate (HS). To this goal untreated AMPs were first incubated
with either 45Ca or '4C uric acid. This procedure was repeated
incubating Ca treated AMPs with 45Ca. After dialysis against
distilled water the percentage bound of added 45Ca and '4C uric acid
was counted. The experiments show: (1) HS and to a lesser extent CS
bind calcium proportionally to their concentration; (2) HS and CS bind
uric acid proportionally to their concentration; (3) AMPs show a greater
affinity for uric acid than for calcium. It is concluded: (1) The inhibitory
activity of AMPs on calcium salts takes place by acting as chelating
agents; to this goal HS seems to be more active than CS, and (2) uric
acid binding to AMPs reduces their availability for calcium, thus
promoting the precipitation of calcium salts.
Suppressor T-cells (sT) in renal transplant recipients: Monitoring by
functional assays and monoclonal antibodies. B. Brando, G. Civati, C.
Rovati, C. Grit/a, M. L. Broggi, G. Busnach, A. Dal Cal, M. L. Nova,
R. Bottelli, A. E. Minetti, M. Surian, C. Guastoni, and L. Minetti.
Divisione di Nefrologia e Dialisi, Ospedale Niguarda Ca' Granda,
Milano, Italy. It is now well achieved that sT cells play a major role in
renal graft tolerance mechanisms. Thirty-nine transplanted patients
were monitored to study the patterns of T lymphocyte subsets as
defined by OKT3, OKT4, and OKT8 ORTHOCLONF. monoclonal
antibodies. At the same time the ConA-enhancement test was per-
formed to study the functional activity of sT (OKT8) cells. All patients
received ATG (IMMOSSAR, Choay), azathioprine, and steroids. Re-
sults were: (1) In uncomplicated patients OKT3 cells were at first
depressed and recovered after about 4 weeks, as did E-rosettes cells.
OKT4 cells were at first very low and recovered slowly with time (r =
0.569, P < 0.001). OKT8 cells were high and decreased slowly (r =
0.24, P = NS). OKT4/OKT8 ratio is thus I for about the first 4 weeks.
(2) sT cell function is first high and decreases slowly, while stimulation
index to mitogens increases exponentially (r = 0.63, P < 0.001). (3)
During rejection episodes, the most striking features are a sudden
increase of OKT4/OKT8 ratio (1.517 0.2 up to 2.764 0.1) and the
diminution or the leakage of sT in vitro activity. During bacterial
infections, OKT4/OKT8 ratio may be increased, while during viral
diseases it is lowered. (4) Immature (OKT4, OKT8, OKT3, or
OKT4, OKT8, 0KT3) cells appear irregularly during the followup.
(5) in all patients, irrespective of the clinical status, OKT4/OKT8 ratio
correlated inversely with sT cell activity (r = 0.41, P < 0.01). On the
contrary, OKT4/OKT8 ratio correlated exponentially with mitogen
stimulation index (r = 0.49, P < 0.001). It was concluded that OKT
cells monitoring, together with functional assays, allowed a better
insight in the immune mechanisms of renal transplant. Suppressor cells
activity seemed to be higher during the periods of deep immunosuppres-
sion achieved by ATG. OKT8 cells seemed to exert a suppressor
activity in renal transplantation, while they may be disturbed function-
ally in other disease.
Body fluid volumes and reflex vascular responses to discontinuation of
diuretic therapy in hypertensive patients. R. Carretta, B. Fabris, G.
Bellini, G. Battilana, A. Bianchetti, and L. Canipanacci. Istituto di
Patologia Medica dell'Universitd, Trieste, Italy. it is generally thought
that antihypertensive treatment has to be continued indefinitely once
initiated. However, it has been reported that, after antihypertensive
therapy has been discontinued, a small number of patients stay normo-
tensive long term. The purpose of this study was to investigate the
relationship between body fluid volumes, baroreceptor sensitivity,
cardiovascular reactivity, and the return of an elevated blood pressure
after diuretic therapy withdrawal in patients with essential hyperten
sian. The study was performed in nine subjects with essential hypejten-
sian (8 males and I female) aged 32 to 58 years (M, 43 6) whose
diastolic blood pressure was between 105 and 130 mm Hg. Plasma
volume (PV), measured by Evans Blue dilution technique, extracellular
fluid volume (ECFV), measured by the thyocianate space, baroreceptor
sensitivity (BRS), assessed by the Smyth's method and vascular
reactivity (VR) to noradrenaline were determined during chronic treat-
ment with hydrochlorotiazide (50 mg/day) + amiloride (5 mg/day) and 6
to 8 weeks after diuretic withdrawal. The results are summarized in the
table:
MAP, mm Hg ECFV, ml PV, ml 1FV, ml
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A 106 3 18.440 3.048 2.946 440 16.152 2.692
*
B 119 9 18.743 2.267 3.213 395 15.529 3.407
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BRS, VR,
PV/IFV mseclmm Hg ng/min 1kg Body wt, kg
A 0.18 0.05 12 5 0.004 0.001 77.1 5
** ** **
B 0.21 0.05 8 + 3 0.005 0.002 77.7 6
Abbreviations are A, parameters assessed during diuretic therapy
and B, after its withdrawal.
< 0.05; ** < 0.01; *** < 0.002
Moreover, PV and PV/IFV correlated directly with MAP after stopping
the diuretic, while such correlations were absent during treatment.
Baroreflex sensitivity, during therapy, correlated inversely with the
patients age and with the rate of return of high blood pressure after
diuretic withdrawal. Stopping the diuretic was followed by an increase
in PV, which appeared related not only to salt and water retention, but
mainly to a redistribution of the body fluid volumes from the interstitial
to the intravascular space. since at this phase ECFV didn't increase. At
the same stage, VR increased while BRS diminished. Diminished BRS
appears to be involved in the blood pressure elevation after discontinua-
tion of antihypertensive therapy, since it correlates inversely with the
rate of return of high blood pressure. From these data it is concluded
that the patients who are likely candidates to stay normotensive long
term, after antihypertensive therapy is discontinued, are younger and
have better baroreflex sensitivity.
Effects of indapamide on arterial reflex and body fluid volumes in
patients with essential and renal hypertension. R. Carretta, B. Fabris, G.
Bell/ni, G. Batti/ana, A. Bianchetti, and L. Ca,npanacci, istituto di
Pato/ogia Medico, Universik) dell' Trieste, ito/v. indapumide is an
antihypertensive agent which in an effective dose of 2.5 mg daily has
minimal diuretic properties. Current evidences suggest that at least part
of its hypotensive activity is due to an effect on vascular smooth
muscle; however, its mode of action remains controversial. The pur-
poses of this study were to evaluate the efficacy of indapamide therapy
and the mode of its antihypertensive action. The study was performed
in ten patients, seven with essential hypertension and three with renal
hypertension, aged 31 to 56 years (M, 42 10). The following
parameters were determined before and after 3 months of therapy with
indapamide, 2.5 mg daily: systolic, dyastolic, and mean arterial pres-
sure (MAP); heart rate (HR); plasma volume (PV), determined by the
Evans Blue (T-1824) dilution technique; extracellular fluid volume
(ECFV), measured by the thyocianate space capillary permeability
(CP), evaluated by the Evans Blue disappearance rate; baroreceptor
sensitivity (BRS), assessed by Smyth's method and vascular reactivity
(VR) to norepinephrine. The results of the study are summarized in the
table:
MAP, mm Hg HR, b/mm ECFV, rn//kg PV, rn//kg IFV, mi/kg
A 141 18 73 Il 247.4 40 39.5 8.5 206 35
*
B 117 II 73 8 270.6 30 40.2 7.7 227 27
PV/IFV CP, Eunit
A 0.20 0.04 0.0031 0.0021
B 0.19 0.05 0.0034 0.0026 13.2 5 0.005 0.003
Abbreviations arc A, parameters evaluated before and B. after
indapamide therapy.
< 0.05; ** < 0.002; *** < 0.001
After 3 months of therapy, indapamide caused an ECFV expansion
which was related essentially to IFV increase. At this stage, an
increased capillary permeability, although not statistically significant,
could explain the observed IFV expansion. At the same time, YR
decreased, while BRS increased. The reduction in vascular sympathetic
tone, related to BRS improvement, and diminution of YR. may result in
vasodilatation. Moreover, the resetting of the baroreceptor threshold
Treatment of renal osteodystrophy (ROD) with 25-OHD3 and 1,25
(OH)2D3: Synergic effect unrelated to 24,25 (OH)2D3 synthesis. G. Coen,
M. Taccone Gallucci, E. Bonucci, P. Ba//anti, A. R. Bianchi, M. C.
Malteucci, S. Picca, G. Bianchini, S. Mazzaferro, G. A. Cinotti, and C.
U. Casciani. Divisione di Nefrologia, I Istiruto di Anatomia Pato/ogica
e V Istituto di Paro/ogia Chirurgica deli' UniversitO, Roma, Italy. The
aim of the study was a comparison of the effects of 1,25 (OH)2D alone
and associated with 25-OHD on ROD of patients on maintenance
hemodialysis. Nine patients (aged 36.1 14.6 years, mean SD) were
treated with 1,25 (OH),D1, 0.25 to I kg/day and 6 (aged 27.6 + 19.3)
with 1,25 (OH)2D3, 0.5 to 2 .ig/day and 25-OHD1, 0.5 to 0.75 p.g/kg/day.
Transiliac bone biopsy was performed before and after 6 to 12 months
of treatment. The bone lesions were of the mixed type. In the first group
serum calcium increased rapidly to normal levels, serum phosphate did
not change significantly, mean alkaline phosphatase remained un-
changed and mean serum IPTH decreased from 39.6 8.1 to 29.8 9.0
mU/mI (NS). Serum 25-OHD3 (25.9 11.7ng/ml) did not change during
treatment. In the second group, while serum calcium and phosphate
showed changes similar to the first group, mean alkaline phosphatase
decreased in four out of six patients, and mean serum iPTH decreased
from 28.8 6.1 to 19.5 + 5.8 mU/mi (P <0.005). Basal values of serum
25-OHD1 (31.1 4.5 ng/ml) increased to 170.1 101.9 ng/ml. During
the treatment period, serum 24,25 (OH)2D3 levels in the two groups
were 2.88 0.39 and 3.71 0,99 ng/ml (NS). Histomorphometric
evaluation in the first group showed significant reduction (P < 0.05) in
total osteoid surface (TOS) and in osteoid volume (OV) while active
osteoblastic surface (AOS) and osteoclastic resorption surface (ORS)
did not change. In the second group a more marked reduction in TOS
and OV was observed. The fall in AOS and ORS was highly significant
P < 0.025 and 0.005, respectively). In conclusion the results indicate
that the combined treatment is more effective than the use of 1,25
(OH)2D alone. The synergic effect of the metabolites is not due to
endogenous synthesis of 24,25 (OH)2D1.
Magnesium (Mg) tubular reabsorption in primary hyperpara-
thyroidism (PH). G. Co/ussi, M. Surian, F. Malberti, G. Barhiano di
I3elgiojoso, G. Marni, A. Aroldi, D. Rura/e, and L. Mmdii. Divisioni di
Nefro/ogia, O.spedali Niguarda e Polic/inico e Divisione di Chirurgia,
Ospedaie Niguarda, Miiano, Italy. Hypercalcemia inhibits, and PTH
enhances, Mg tubular reabsorption. However, the role of PTH-depen-
dent Mg renal reabsorption in the control of Mg metabolism has still to
be established. We evaluated this issue in ten surgically proven PH
patients and in seven healthy subjects (N). PH patients had higher
fasting Mg excretion rate (MgE, 54 24 i.g/dl GFR) and fractional
excretion of diffusible Mg (FEMg, 4.3 2.4%) than N (34 9 and 2.8
0.9, respectively, P < 0.05), despite no differences in total and diffusible
Mg plasma levels (PH 1.8 0.2 and 1.3 0.2 mg/dl, respectively; N
— 2.0 0.2 and 1.24 0.1). In PH patients fasting MgE was correlated
directly with fasting calcium excretion rate (r = 0.83, P < 0.01) and with
filtered load of diffusible calcium (r = 0.63, P < 0.05). In 5 N an iv.
infusion of CaCI2 (IS mg/kg/4 hr) increased plasma calcium to similar
levels as in PH patients (11.7 0.8 vs. 11.8 1.2): The corresponding
values of MgE were significantly higher in N (110 30) than in PH
patients (P < 0.001). Renal Mg threshold (TmMg/GFR) was evaluated
by infusing MgSO4 (20 mg/kg/4 hr) in 5 N and 5 PH patients: Mean
values were significantly higher in PH patients (2.42 0.2 mg/dl GFR)
than in N (2.05 023. P < 0.05). In conclusion, in hypercalcemic PH
patients, fasting MgE is higher than in N, but is lower than in N made
hypercalcemic by calcium infusion. According to our data, the satura-
tion curve of Mg tubular reabsorption shows a higher reabsorption
capacity (Tm) and a larger splay in PH patients as compared to N; while
the first effect is likely to be due to increased PTH secretion, the second
one seems to be related to hypercalcemia.
The glomerular dynamics in the pregnancy during extracellular fluid
volume expansion. A. Dal Canton, G. Conte, C. Esposito, G. Fuiano, R.
Guasco, D. Russo, M. Sabbatini, R. Uccello, and V. E. Andreucci.
Istituto di Nefro/ogia Medica, II Facoltd di Medicina dell' UniversirO,
Napoli, ira/v. in this study, glomerular dynamics were investigated by
micropuncture in 15-day pregnant Munich-Wistar rats. Female non-
could explain the lack of tachycardia following indapamide
vasodilatation.
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pregnant rats were used as control. In hydropenia, single nephron
glomerular filtration rate (SNGFR) averaged 37.2 nl/min/g kidney wt in
pregnant rats, and 26.2 nl/min/g kidney wt in controls (P < 0.0005).
During pregnancy, mean glornerular plasma flow (GPF) rose from 63.0
to 104.5 nl/min (P < 0.0005), and glomerular capillary hydrostatic
pressure (P0) from 44.8 to 50.6 mm Hg (P < 0.0005). This rise in P
accounted for an increase in effective filtration pressure (EFP). Mean
EFP at the efferent end of the glomerulus rose from near zero to 9.7mm
Hg, indicating filtration pressure disequilibrium. After extracellular
fluid volume expansion with saline, GPF and EFP were still greater
during pregnancy. A filtration pressure disequilibrium occurred also in
nonpregnant rats, allowing calculation of definite values of the ultrafil-
tration coefficient (Kf). During pregnancy, mean Kf was reduced from
0.0332 to 0.0285 nl/(sec mm Hg) (P < 0.005). SNGFR was moderately,
but not significantly increased. These results show that during pregnan-
cy glomerular dynamics is characterized by a rise in GPF and EFP, and
by a reduction in K. Following these changes, a plasma-flow dependent
rise in SNGFR occurs in hydropenia. After expansion, instead, SNGFR
is unmodified because the dependence of ultrafiltration on plasma-flow
declines while the influence of Kf increases at high values of GPF.
Circulating immune complexes (CIC) in IgA glomerulonephritis (IgA-
GN): Their valuation and determination of immunoglobulins (Ig) forming
CIC by an amplified conglutinin binding micro assay (AKgB-MA). P. P.
DaIl'Aglio, G. Balestrieri, L. Allegri, E. Brianti, R. Cattaneo, E.
Ciccone, and A. Tincani. Cattedra di Immunologia Clinica e Istituto di
Clinica Medica e Nefrologia, Universitd, Parma and Servizzo di
Iminunologia Clinica, Spedali Civili, Brescia, Italy. In 21 patients with
IgA-GN, determined by renal biopsy examined by light, electron
microscopy, and immunofluorescence, CIC were investigated in blood
specimens taken before the biopsy by different methods: (1) C3q binding
test (CIQ-BA); (2) conglutinin test (KgB-SP); (3) amplified conglutinin
binding microassay (AKgB-MA). In the latter the amplification, in
comparison to KgB-SP, was obtained by anti-immunoglobulin antibod-
ies. Initially each serum was incubated in four different conglutinin
coated tubes, allowing the binding of IC; then, after washing, different
rabbit monospecific sera antihuman IgO, IgA, and 1gM were added in
three tubes only; again after washing, equal quantities of 125J protein A
were added; finally radioactivity was valued by gamma counter, and the
value of the tube without rabbit antiserum was subtracted from the
values of tubes with antisera. KgB-SP resulted positive in 7 out of 21
patients (33.3%) and CIQ-BA in 3 out of2l (14.3%). By AKgB-MA CIC
were observed using serum anti-IgG in 10 out of 21 (47.6%), anti-IgA in
4 out of 21 (19.0%), anti-IgM in 3 out of 21 (14.3%), in total in 10 out of
21(47.6%). AKgB-MA showed in all CIC presence of IgG in prevailing
concentration, in one case associated to igA and 1gM, in three to IgA
only, and in two to 1gM only. Therefore, AKgB-MA appeared more
sensitive than KgB-SP and C1Q-BA; besides (showing the CIC compo-
sition) it demonstrated some differences between dC, formed preva-
lently by IgG, and renal immunocomplexes (detected by immunofluo-
rescence), which mainly contained IgA in glomerular mesangium.
These results could suggest a different pathogenesis of CIC and
glomerular IC, the latter probably formed in situ, or following the
deposition of CIC coated with antiglobulins.
The use of cyclosporin A in patients receiving renal allografts from
cadaver donors. W. Huber, M. Spielberger, P. Riegler, F. Neurnair, R.
Benelli, B. Giacon, D. Di Landro, and R. Margreiter. Divisione di
Nefrologia, Ospedale Regionale, Bolzano, Italy-Transplant Service, I
Department of Surgery, University, Innsbruck-Servizio di Emodialisi,
Ospedale Regionale, Padova, Italy. Beginning in November 1980, 27
kidney transplant patients were treated (13 female, 14 male, mean age
41 11 years, ranging from 11 to 54 years), who diuresed within 6 hr,
with Cyclosporin-A (Cy-A) initially as the sole immunosuppressive
drug. The following doses were used: (I) from the 1st to the 14th day 17
mg/kg/day; (2) from the 15th to the 45th day 15 mg/kg/day, dropping
afterwards 2 mg every month until a maintenance dose of 7 mg/kg/day
was reached. Because of the appearance in the first few days of oliguria
due to ATN, seven patients were changed from Cy-A to conventional
treatment with' steroids and azathioprine. in one patient it was neces-
sary to suspend the immunosuppression because of serious viral
pneumonia resulting in loss of the kidney. Eleven patients are still being
treated with Cy-A as the sole immunosuppressive drug (mean observa-
tion period 5.6 months; range, 2 to 8 months): Two of these patients
have never presented rejection crisis, while the rejection episodes of the
remaining nine patients were treated with infusions of methylpredniso-
lone. The mean value of S-creatinine in these II patients at the latest
control was 2 0.9 mg% (range, 1.2 to 3 mg%). Eight patients were
changed from Cy-A to conventional immunosuppression with steroids
and azathioprine because of the appearance of side effects; the most
important of these were nephrotoxicity and hepatic dysfunction, both of
which disappeared after suspension of Cy-A.
Effect of a new diuretic agent (azosemide) on peritoneal transport. G.
La Greca, S. Biasioli, A. Bogoni, S. Chiaramonte, A. Fabris, M.
Feriani, L. Martimbianco, E. Pisani, C. Ronco, F. Tasinazzo, and F.
Zen. Divisione di Nefrologia, Servizio di Medicina Nucleare e Servizio
di Laboratorio, Ospedale S. Bortolo, Vicenza, Italy. A new diuretic
agent (azosemide—BS 510, 370.8 daltons) was added to the dialysis
solution in eight patients (five male, three female, aged 23 to 62) on
intermittent peritoneal dialysis from almost 6 months. All the patients
were in stable clinical condition and had a good peritoneal membrane
efficiency. Azosemide showed in animals and healthy voluntary sub-
jects properties quite similar to those of furosemide but a more delayed
and prolonged diuretic effect. Ultrafiltration, clearances of urea, creati-
nine, uric acid, phosphorus and transfer of Na, K, Cl were studied in
different dialytic schedules (dwell time 0'—15'—30'). The dialysate
volume was determined on each exchange by means of serum albumin
radio-iodine (l) added in doses of 25 sCi to each 2 liters exchange.
The residual peritoneal volume was evaluated from the difference
between the inflow-outflow radioactivity. Azosemide was added to the
dialytic solution in doses of 10 or 20mg/liter. As previously demonstrat-
ed by other investigators using furosemide and ethacrinic acid, we
could not observe in our azosemide patients any important variation in
the dialysate volume. Azoseniide, added to the hypertonic solution
(dextrose 4,25%) in doses of 10 mg/I—dwell time 15—showed signifi-
cant increases of the clearances of creatinine (18%). urea (16%), uric
acid (15%), and phosphorus (8.5%). Under the same conditions, an
increase of Na (8.5%) and K (8.8%) extractions yias observed, Azose-
mide, using 1.5% dextrose solution and different dwell time, showed no
efficacy or sometime paradoxical effects. Our data suggest that this new
diuretic may be useful only for the study of peritoneal membrane
efficiency.
Brain morphodensitometrical analysis in endstage renal disease and
dialyzed patients. Studies with a computerized technique. G. La Greca,
P. Dettori, S. Biasioli, S. Chiara,no,ne, A. Fabris, M. Feriani, V.
Pinna, F. Pisani, and C. Ronco. Divisione di Nefrolcgia e Servizio di
Neuroradiologia, Ospedale S. Bortolo, Vicenza, Italy; During our
previous researches we could state that dialyzed population shows a
decrease of densitometrical values of the brain immediately after each
dialysis session. No important morphological variation was contempo-
raneously demonstrated. On the basis of these results we applied new
techniques of computerized tomography (CT), areas of mean density.
diagrams of density and isodensity maps with radiolucent points, on 15
healthy voluntary subjects, 15 uremic and 35 dialyzed patients. The
dialysis population was divided into five groups: HD with acetate, 12;
I-ID with bicarbonate, 5; combined dialysis and ultrafiltration, 6;
intermittent peritoneal dialysis, 6; continuous ambulatory peritoneal
dialysis, 6. The analysis of more than 600 images obtained in sequential
CT examinations carried out before and after dialysis and in the
interdialytic period, led us to gain some conclusions. The mean cerebral
density of uremic nondialyzed people is similar to normals. In intermit-
tently dialyzed population, basal density is significantly higher than in
controls, reaching normal values only after dialysis. CAPD patients do
not show any densitometrical change. It is therefore probable that the
dialysis encephalopathy may be due to the cerebral swings in water
content: In the interdialitic period the brain becomes more and more
dry as demonstrated by the increasing of objective density, while during
each session a tendency toward a normal water content is registered.
Whether this trend may be due to osmotic changes or to physiocheniical
factors, is actually under estimation.
Evaluation of renin-dependent hypertension in nephropathic patients
and orally converting enzyme inhibitor (CE!). S. Lamperi, S. Carozzi, D.
Trasforini and U. Benizzelli. Divisione di Nefrologia, Ospedale S.
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Martino, Genova, Italy. In 36 hypertensive patients with bilateral
(BVPA) or unilateral (UVPA) vascular or parenchymal renal abnormali-
ty and in six normal subjects used as control, the behavior of blood
pressure (BP), plasma renin activity (PRA), plasma renal flow (PRF)
was investigated. These evaluations were made on the said patients in
the supine position or on tilting upright to 700 before and after a single
dose of CEI (SQ 14225, 100 mg), in sodium balance or in salt restriction
periods with the precise aim to discover patients whose hypertension
depends upon excessive angiotensin 11 activity. The same study has
been carried out in hypertensive patients with LJVPA also on blood
samples obtained from the renal veins to study the ratios of the values
of said parameters in each kidney in similar experimental conditions.
Thirteen patients with BVPA and four with UVPA did not show any
evidence of renin release or of blood pressure decrease: It must be
admitted that in these patients the excessive angiotensin production is
not the cause of hypertension (CEI nonresponders). Six subjects with
BVPA and four with UVPA showed a mean significant BP decrease
from 210/115 mm Hg to 130/85 mm Hg and a marked PRA increase from
0,5 to 35 ng/ml/hr already in salt supplied period, dissimilarly to the
normal subjects. The hypertension of these patients can be identified as
"renin-dependent form." It showed the best results to the SQ 14225
administration as therapeutic cure and to the surgical treatment (CEI
responders). Five subjects with BVPA and four with UVPA showed
similar decrease in BP from 210/120 mm Hg to 120/80 mm Hg and
increase in PRA from 3 to 55 ng/ml/hr but only in salt restriction
condition, similarly to normal subjects: This hypertension can be
identified as "possible renin-dependent form." It showed inconstant
results to the medical and to the surgical treatments (CE! false-negative
responders). Our experience appears therefore to suggest that CE! (SQ
14225) can be useful to identify diagnostically renin-dependent forms of
hypertension and to establish,the most suitable therapy.
Familial nephropathy: Analysis of 42 cases. V. Mb/i, M. Ragaiolo, E.
Lombardo, R. Montironi, S. Cinti, C. Parravicini, and F. Osculati.
Divis lone di Nefrologia, Istituto di Anatomia Patologica, Istituto di
Anatomia Umana norma/c deli'Universitd, Ancona, Italy. Out of 25
families, 42 patients with hereditary nephropathy (HN) were identified.
All the patients were studied by clinical investigation, renal and
audiometric function, renal and skin biopsy, and genetical observation.
Hystologic findings (light, fluorescence and electronic) enabled us to
diagnose: Hereditary glomerulonephritis (HG), included Alport syn-
drome, in 25 patients, and idiopathic benign familial hematuria (IBFH)
in 17 patients. The early clinical picture was: asymptomatic microhema-
tuna in 31 patients; recurrent macrohematuria in seven patients;
nephrotic syndrome in two patients and nephritic syndrome in two
patients. In all the patients but one, GFR/1.73 m2 was up 80%. The
damage of audiometric function was present as follows: nerve deafness
in 27 patients (24 patients with HG and three patients with IBFH) and
bone deafness in seven patients, all with IBFH. Hystologic pattern
(light and immunofluorescence) did not show pathognomonic lesions.
On the contrary, specific electronic findings were observed, that is,
lamellation and fragmentation of the basement membrane in the HG
cases and a diffuse thinning in the IBFI-I patients. In both groups the
"particles" in the lamina densa and the focal thickening of the lamina
rara interna were observed. The chromosomial maps and the prelimi-
nary HLA system studies do not present significant abnormalities. Our
pedigree studies prove autosomal dominant inheritance, while the
variable clinical picture suggests that both groups could be considered
as an unique disease. The 66 months of average observation (14 months
to 18 years) led to these conclusions: (1) slow and benign evolution in
the IBFH; (2) more rapid and poorly evolution in the HG, particularly in
the patients with nerve deafness or with lenticono; (3) ineffectiveness of
the therapy.
Antagonism between juxtaglomerular alpha and beta adrenoceptors in
the regulation of renin release in man. A. Morganti, C. Sala, A.
Palermo, L. Turolo, andA. Zanchetti. Islitwi diRicerche Cardiovasco-
Ian, CNR, Pato/ogia Medica I e C/mica Medica VII, Universitd,
Milano, Italy. Several investigations in vitro, in the isolated kidney and
in the experimental animal, indicate the existence of juxtaglomerular
alpha-adrenoceptors (n-AR) with a direct suppressive action on renin
release which counteract the stimulating action of the 3-adrenoceptors.
Evidence for this is difficult to obtain in man since systemic stimulation
or blockade of the a-AR is accompanied by variations in blood pressure
(BP) which may affect the release of renin through the intrarenal
baroreceptor mechanisms. In the attempt to dissociate a direct action of
a-AR blockade on renin release from that on BP, we studied the
changes in plasma renin activity (PRA) following an isoproterenol (1)
challenge (8 ng/kg/min infused for 10 mm) before and during a1-AR
blockade induced with a small dose of prazosin (P) (0.25 mg given iv.
over 2 mm); the degree of a-AR blockade was assessed by comparing
the pressor responses to 1.5 jig/kg of phenylephrine (PETE) before and
after P. The study was performed in seven patients with essential
hypertension. In control conditions, I increased PRA (ng/ml/hr) from
1.5 0.2 to 2.6 0.8 (P < 0.02) and slightly lowered mean BP (mm Hg)
from 128 3 to 125 4 (NS). Prior to P infusion, both PRA and BP
were allowed to return to baseline levels (1.5 0.3 and 131 3). After
P, PRA increased within 30 mm up to 2.9 0.6 (P < 0.02) without
concurrent changes in BP (129 3), whereas the pressor response to
PHE was abolished by 80 3% with respect to control (3 1 vs. 15
2). The subsequent infusion of! caused a further increase in PRA to 6.4
1.7 (P <0.02) and no change in BP (128 3); the responses of PRA to
I were greater after than before P both in absolute and percent values
(+3.5 1.2 vs. +1.1 0.7 and +124 51 vs. +64 39%, P <0.02 for
both). Since during nonhypotensive al-AR blockade baseline PRA is
increased and the response of PRA to I enhanced, it is concluded that in
man the juxtaglomerular a1-AR participates in the regulation of renin
release with an inhibitory action which antagonizes the stimulating
influence of the 3-adrenoceptors.
Glucose metabolism in CAPD patients: Intravenous glucose load and C
peptide, insulin and glucagon variations. G. Panzetta, R. Broccoli, S.
Sandrini, and R. Maiorca. Divisione di Nefrologia, Spedali Clviii,
Brescia, Italy. Some aspects of glucose metabolism in CAPD patients
were studied. The correction of glucose intolerance is well documented
in hemodialysis patients, whereas no definite data are available in
CAPD patients. Moreover the influence of the high glucose absorption
from the peritoneal fluid has not yet been evaluated. Chronic uremic
patients on diet and hemodialyzed patients were compared with the
CAPD patients. Sixteen CAPD patients (age 61 10 years, dialysis
duration 6.5 4 months), 31 uremic patients (age 50 12 years,
creatinine clearance 5 to 50 mI/mm), 32 dialyzed patients (age 45 14
years, dialysis duration 46 38months) and nine normal subjects were
given an intravenous glucose load. Plasma glucose, insulin, C peptide
and glucagon were measured. The glucose tolerance test was normal in
50% of uremic patients on diet, in 63% of CAPD patients and in 94% of
hemodialyzed patients. Basal plasma insulin was significantly higher
(three times higher than normal) only in CAPD patients. The plasma
glucagon, although higher than in controls, was normally suppressed by
glucose in all three groups of patients. The early increase of the C
peptide. which was considered the most reliable index of insulin
secretion, was found significantly lower than normal only in CAPD
patients. Although a better response in glucose tolerance test was
observed in CAPD than in uremic patients, the dialyzed patients
showed normal response in a higher percentage of cases. Nevertheless,
no difference was noted in glucose tolerance when only the CAPD
patients of the same age of hemodialyzed patients were considered. The
low early increase in C peptide suggests an impaired prompt insulin
secretion in CAPD patients. It is possible that the basal insulin
oversecretion, due to glucose absorption from the peritoneal fluid,
causes a depletion of insulin stores in the 3-cells. For this reason a less
prompt insulin release may occur immediately after the stimulation.
Captopril in the treatment of essential hypertension: Long-term clinical
study. A. Pie,'ucci, B. M. Simonetti, S. Feniozzi, M. Manzi, G. Stirati,
and G. A. Cinotti. Divisione di Ivefrologia del/'Univers bid, Roma, Italy.
Isolated proteinuria or nephrotic syndrome without modifications of
renal function has been reported as a clinically relevant side effect
during captopril (C) (an oral angiotensin converting enzyme inhibitor)
treatment. The present investigation was undertaken to evaluate: (1) the
persistence of the antihypertensive effect and (2) the incidence of side
effects, particularly the occurrence of renal damage, during long-term
treatment with C. A group of 24 patients with essential hypertension (II
women, 13 men; mean age, 42 8.5) was studied. All patients failed to
respond adequately to conventional therapy. Mean arterial pressure
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(MAP) in clino- (c) and in ortho-statism (o). serum creatinipe (sC),
urinary sediment, proteinuria were evaluated. C was given for 15
consecutive months at a dose of 25 mg t.i.d., increasing the dose, at
intervals of one week, to 50 and 150 mg t.i.d. depending on the
antihypertensive response obtained. In 64% of patients the pressure
values (diastolic arterial pressure >90 mm Hg) had failed to reach
normal levels at the beginning of the fourth week and chlortalidone was,
therefore, associated at the dose of I dl every other day. Results are
summarized in the table (m SD):
MAP
c o P sC
Control 127.0 10.88 128.0 10.57 0.94 0.24
Third month 104.0 11.52 104.8 8.59 <0.001 1.01 0.32 NS
Ninth month 104.7 4.99 106.2 9.16 <0.001 1.06 0.28 NS
15th month 95.4 6.97 99.1 7.55 <0.001 0.90 0.18 NS
Administration of C was withdrawn during the first month of treatment
in 25% of patients due to the appearance of the following side effects:
skin rash (8.3%), epigastric pain (8.3%), pruritus (4.2%), and taste
disturbances (4.2%). We conclude that: (1) Once the optimal dose for
each patient was reached, the antihypertensive effect remained stable;
(2) the appearance of side effects occurred within the first month of
treatment; (3) during long-term administration of the drug, no evidence
of renal damage was observed.
Multicentric study on CAPD in Italy: A preliminary report. G. P.
Segoloni, study coordinator Ospedali: S. Giovanni e Molinette, Torino;
S. Carlo Borromeo, Milano; Niguarda, Milano; Kroff, Milano; di
Circolo, Varese; Provinciale, Busto Arsizio; Civile, Brindisi; Civile,
Piacenza; Malpighi, Bologna; S. Maria, Ravenna; Riuniti, Parma; S.
Bortolo, Vicenza; S. Martino, Genova; S. Maria, Siena; Monteluce,
Peru gia; S. Maria, Reggio Emilia. A multicentric study has been
carried out in 17 Italian Centers in which a standardized procedure of
CAPD has been applied to 405 patients. The study lasted 15 months.
The data have been subsequently analyzed by a computer program
(SPSS). Particular interest has been addressed to seven problems: (I)
organizing problems and a clear definition of hemodialyses/CAPD ratio;
(2) definition of the population and selection criteria in the 17 centers
(sex, age, center distance, disease, and so forth); (3) treatment; (4) side
effects of the treatment and hospital admission rate; (5) followup of the
patients and peritoneal clearances' changes; (6) psychological reac-
tions; (7) nutritional parameters. The results indicate that CAPD in Italy
is an important procedure either for home treatment of the patients or as
new therapeutic approach.
Plasma exchange and glomerulonephritis. R. Sinico, M. L. Parac-
chini, A. Fornasieri, S. Benuzzi, G. Pagella, A. Gibelli, and G.
D'Amico. Divisione di Nefrologia e Servizio di Immunoemalologia,
Ospedale S. Carlo Borromeo, Milano, Italy. Plasma-exchange has been
used in addition to corticosteroids and immunosuppressive in 17
patients with histological evidence of severe GN. The patients have
been divided into three groups: First group. Seven patients had
idiopathic crescentic GN and rapidly progressive renal failure, five of
them requiring dialytic treatment. Plasma-exchange dramatically im-
proved the GFR of four patients allowing them to stop any substitutive
therapy. Second group. Four patients had severe proliferative lupus
UN, who failed to respond to conventional treatment and showed
tendency to renal failure; in three of them it was possible to stop the
impairment of GFR and to restore it to normal values. Third group. Six
patients had UN associated with essential mixed cryoglobulinemia.
Four cases presented with acute nephritic syndrome and showed a
massive formation of intraglomerular 'thrombi": In three of them
plasma-exchange treatment was followed by a dramatic improvement,
whereas the fourth one died for an uncontrolled necrotizing vasculitis.
The two other patients presented with severe proliferative UN and
nephrotic syndrome, and plasma-exchange 4id not infuence their slowly
progressing renal failure. The mode of action of plasma-exchange is still
debated (we have noticed a reduction in circulating immune complexes
only in the four patients of the lupus-GN group) and its real usefulness
can be hardly assessed in patients usually treated with a number of
drugs. Nevertheless, we suggest that plasma-exchange should be used
as supportive treatment for all patients with potentially "fulminating"
UN.
Protein-calprie malnutrition (CM) in chronic uremic patients (CUP)
in conservative treatment (CT), regular hemodialysis (RDT) or continu-
ous ambulatory peritoneal dialysis (CAPD). G. Toigo, R. Situlin, G.
Fasola, G. Bazzato, U. Coli, S. Landini, A. Raimondi, G. F. Guarnieri,
and L. Campanacci. istituto di Patologia Medica dell' Universitd,
Trieste, Italy. Many factors negatively affecting the nutritional status
have been described in chronic uremic patients and a strong correlation
between malnutrition and mortality has been often reported. The aim of
nutritional therapy in patients with chronic uremia is to minimize
protein toxicity, while maintaining good nutrition. The beneficial effects
of dietary protein restriction often result in protein malnutrition.
Besides, other nondietary causes of PCM are often present. Nutritional
therapy is therefore an important aspect of management of CUP in CT
or in dialysis. For the treatment of malnutrition a preliminary nutritional
assessment is required. Using single indexes for nutritional status
assessment, the true prevalence of PCM may be underestimated.
Therefore, in the present study, we evaluated the nutritional status of
CUP undergoing CT, RDT or CAPD by means of: (1) anthropometric
measurements, (2) biochemical determinations (serum albumin, trans-
terrin, C3', C3' activator and pseudocholinesterase content), (3) indexes
of muscle protein metabolism (DNA, RNA, and alkali-soluble proteins
(ASP) content, RNA/DNA and ASP/DNA ratios) determined by means
of micro-methods on muscle biopsy specimens. The RNA/DNA and
ASP/DNA ratios have been used as indexes of efficiency of protein
synthesis in the largest body's protein pool, the striate skeletal muscle.
The results were as follows:
CT RDT CAPD
Albumin,
mg/dl 2760 554 3487 385" 2246 682
Transferrin,
mg/dl 226 64.7 236 85 201 58
PCHE,
mU/mI 1715 547 2996 818 2019 1007
C3' 83.5 23.38 82 21 102 20
C3' activator 18.9 5.21 18 5 21 8
RNA/DNA 1.60 0.44 1.87 0.35 1.67 0.29"
ASP/DNA 403 91" 395 135" 317 69
Patients vs. controls "P < 0.05; P < 0.01; cp < 0.005; d < 0.001.
RTD patients vs. CAPD patients: "P < 0.001.
Fat deposits were reduced in CT and RDT patients, normal or high in
CAPD patients. These results confirm the high prevalence of PCM in
CUP: The malnutrition seems to be marginal for the patients in RDT
and more severe in CT patients. Nutritional indexes are depressed
severely in CAPD patients: Both the "visceral" and muscle protein
synthesis are affected, even in the presence of normal body weight and
anthropometric measurements. The malnutrition of these patients could
be ascribed to a low dietary protein intake (1.02 g/kg bw/d) and the
peritoneal protein loss. A larger protein intake (up to 1.4 g/kg bw/day)
seems to be a correct approach to dietetic treatment in CAPD patients.
